Evolutionary characterization of lung adenocarcinoma morphology in TRACERx.
Nat Med
29:
2023
833-845
|
27
|
Genomic-transcriptomic evolution in lung cancer and metastasis.
Nature
616:
2023
543-552
|
56
|
Antibodies against endogenous retroviruses promote lung cancer immunotherapy.
Nature
616:
2023
563-573
|
94
|
The evolution of non-small cell lung cancer metastases in TRACERx.
Nature
616:
2023
534-542
|
59
|
The evolution of lung cancer and impact of subclonal selection in TRACERx.
Nature
616:
2023
525-533
|
86
|
Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA.
Nature
616:
2023
553-562
|
84
|
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance.
Nat Genet
56:
2024
60-73
|
22
|
Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer.
Cancer Discov
14:
2024
1018-1047
|
19
|
Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models.
Nat Commun
15:
2024
4653
|
6
|
Deep cell phenotyping and spatial analysis of multiplexed imaging with TRACERx-PHLEX.
Nat Commun
15:
2024
5135
|
0
|
MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution.
Nat Genet
56:
2024
2121-2131
|
5
|
Imaging NRF2 activation in non-small cell lung cancer with positron emission tomography.
Nat Commun
15:
2024
10484
|
1
|
TRACERx analysis identifies a role for FAT1 in regulating chromosomal instability and whole-genome doubling via Hippo signalling.
Nat Cell Biol
27:
2025
154-168
|
1
|
Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma.
Nat Med
31:
2025
70-76
|
0
|